You have 9 free searches left this month | for more free features.

AZD4017

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Intracranial Hypertension Trial in Birmingham (AZD4017, Placebo)

Completed
  • Idiopathic Intracranial Hypertension
  • AZD4017
  • Placebo
  • Birmingham, West Midlands, United Kingdom
    University Hospital Birmingham (Queen Elizabeth Hospital)
Sep 28, 2021

Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)

Completed
  • Iatrogenic Cushing's Disease
  • AZD4017 and prednisolone
  • Placebo Oral Tablet and prednisolone
  • Oxford, United Kingdom
    University of Oxford
May 12, 2021

Diabetes, Type 2 Trial in Leeds (AZD4017, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • AZD4017
  • Placebo
  • Leeds, United Kingdom
    Leeds Teaching Hospitals Trust
Mar 21, 2019

COPD COPD Trial in Worldwide (AZD7624 1.0 mg, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease COPD
  • AZD7624 1.0 mg
  • Placebo
  • Los Angeles, California
  • +40 more
Apr 26, 2018

Raised Intraocular Pressure Trial in Sweden, United Kingdom, United States (AZD4017, Placebo)

Completed
  • Raised Intraocular Pressure
  • AZD4017
  • Placebo
  • Newport Beach, California
  • +10 more
Jan 20, 2014

Obesity Trial in Goteborg (AZD4017, Placebo)

Completed
  • Obesity
  • AZD4017
  • Placebo
  • Goteborg, Sweden
    Research Site
Dec 9, 2010

Diabetes Type 2 Trial in Gothenburg (AZD4017, Placebo)

Completed
  • Diabetes Mellitus Type 2
  • AZD4017
  • Placebo
  • Gothenburg, Sweden
    Research Site
Sep 29, 2009

Healthy Trial in Fukuoka (AZD4017, Placebo)

Completed
  • Healthy
  • AZD4017
  • Placebo
  • Fukuoka, Japan
    Research Site
Jun 30, 2009

Healthy Trial in Gotteborg (AZD4017, Placebo)

Completed
  • Healthy
  • AZD4017
  • Placebo
  • Gotteborg, Sweden
    Research Site
Jun 15, 2009